Future directions for multidisciplinary consensus on the definition of resectable NSCLC

Clinical case review for the definition of resectable NSCLCПодробнее

Multidisciplinary consensus for the definition of resectable NSCLCПодробнее

The future of chemo-immunotherapy in resectable non-small cell lung cancerПодробнее

WCLC 2024 Highlights - Exploring Latest Advances in Lung Cancer TreatmentПодробнее

Future Directions in Treating NSCLCПодробнее

Neoadjuvant Nivolumab in Resectable Lung Cancer | NEJMПодробнее

Future directions for lung cancer researchПодробнее

Does perioperative therapy and surgery have a role in stage III NSCLC?Подробнее

Future directions in lung cancer immunology researchПодробнее

Future Directions for Liquid Biopsy in NSCLCПодробнее

Current treatment recommendations and future directions for EGFR-mutant NSCLCПодробнее

FDA Approves Durvalumab / Imfinzi for Resectable NSCLC Non-Small Cell Lung CancerПодробнее

Dr. Jared Weiss: Stigma, Future Directions, and Hope for Small Cell Lung CancerПодробнее

Future Directions for ALK+ NSCLCПодробнее

Dr Backhus on Defining Borderline-Resectable Lung CancerПодробнее

Molecular Testing: Future Directions in NSCLCПодробнее

Future directions for neoadjuvant immunotherapy in lung cancerПодробнее

Liquid biopsy: future directions for ctDNA in NSCLCПодробнее